Akso Health Group
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Xiaobo An
- Full Time Employees
- 113
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 5Th Floor, Block C, Shimao No. 92 Jianguo Road Cha Beijing People's Republic of China 100020
- IPO Date
- Nov 3, 2017
- CIK
- 0001702318
- Website
- xiaobaimaimai.com
- Similar Companies
- Business
- Akso Health Group (NASDAQ: AHG), formerly Xiaobai Maimai Inc., operates a social e-commerce platform and integrated healthcare technology services provider focused on the Internet + Healthcare sector in the People's Republic of China. The company offers a comprehensive suite of products and services, including medical and health mall services for technology-enabled healthcare products and devices such as defibrillators and anesthesia laryngoscopes; telemedicine platforms encompassing intelligent internet hospital functionalities with online image, text, voice, and video consultations, electronic prescriptions, express medicine delivery, home-based nursing services like injections and infusions, intelligent appointment registration based on symptoms, public health emergency monitoring and early warning systems, telemedicine collaboration tools for remote clinics, consultations, ward rounds, and nursing; offline cancer treatment services; vaccine research and development services; health treatment and consultancy support; remote consultations and chronic disease management programs; corporate wellness solutions; integrated electronic medical records (EMR), patient management tools, and graphical consultations; family health files; and medical services for querying records, appointments, and drug orders. Akso Health Group, founded in 2014 and headquartered in Qingdao, Shandong Province, China, primarily serves patients, healthcare providers including hospitals and clinics, corporate clients, and consumers through its SaaS-based digital platforms and direct services, with operations centered in China and ambitions for global health management expansion. Recent developments include a strategic pivot in late 2021 to healthcare with key acquisitions such as controlling interests in App Fission Ltd. for mobile health apps and Guizhou Yongrenhutang Pharmaceutical Chain Co., Ltd. for pharmacy operations; a January 2024 announcement of plans to acquire an online clinic business to build a comprehensive medical technology service platform starting in China; integration of DeepSeek's artificial intelligence technology in 2025 to upgrade its AI-powered diagnosis system with multimodal large-scale models for processing patient text, medical imaging, and lab results to deliver accurate diagnoses and personalized treatment recommendations, alongside development of an AI medical assistant for doctors; and strategic initiatives for 2025 emphasizing expansion of health products on its social e-commerce platform, enhancement of mobile health app features, pursuit of collaborations with healthcare institutions, and operational efficiency optimizations amid reported revenue growth to $14.78 million for fiscal year 2024, up 512% year-over-year.
HX Stock: Why The Price Substantially Increased
HX Stock Drastically Increases This Past Week
Xiaobai Maimai Files Annual Report on Form 20-F for Fiscal Year 2021
Xiaobai Maimai Announces Changes to the Management and Board of Directors
Xiaobai Miamai Contributed to the Drafting of "Social e-Commerce Enterprise Operational Service Standards", Officially Launched by CATIS in February 2021
Xiaobai Maimai Joins Leading Industry Associations to Formulate "Social e-Commerce Enterprise Operational Service Standards"
Xiaobai Maimai Reports Unaudited Financial Results for First Half of Fiscal Year 2021
Xiaobai Maimai to Report Unaudited Financial Results for First Half of Fiscal Year 2021 on December 21, 2020
Hexindai Announces the Results of Annual General Meeting and Name Change
Hexindai Announces Disposition of P2P Business to Focus on Developing Social E-Commerce Platform Xiaobai Maimai
Hexindai to Hold Annual General Meeting on December 16, 2020
Contraceptive Drugs and Devices Market Size Report Forecast 2020 – 2024 Business Revenue, Opportunities, Future Growth, Trends Plans, Top Key Players, Global Analysis by Share
Electrochemical Flow Cells Market Growth, Industry Trends 2020 Size by Regions, Global Industry Share, Sales Revenue and Opportunities till 2026 with COVID-19 Impact
Financial Contrast: Weidai (NYSE:WEI) vs. Hexindai (NYSE:HX)